Launch a Longevity & Peptide Therapy Telehealth Service Line
Physician-directed optimization programs supported by lab panels, with an added layer of compliance review in the highest regulatory-risk category we support.
A wellness category that needs extra compliance care
Longevity and peptide therapy covers wellness-oriented optimization services, including growth-hormone secretagogues, NAD+, and recovery and anti-aging peptides, typically delivered as physician-directed protocols.
It is the highest regulatory-risk category in the TelePartners Studio model. Most products are compounded and not FDA-approved for the marketed indication, so this service line runs with additional compliance review, lab-guided protocols, and state-licensed pharmacy fulfillment. New to the model? See how TelePartners Studio works or read about us.
What your longevity and peptide therapy service line can cover
Physician-directed peptide protocols
Growth-hormone-releasing peptide protocols, only where counsel confirms current status.
NAD+ programs
NAD+ and recovery-focused optimization programs, compounded and off-label.
Hormone support
Compounded testosterone and DHEA support agents, overlapping with men's and women's health.
Personalized lab panels
Baseline and follow-up panels that keep programs lab-guided over time.
Added compliance review
Counsel review of each substance before it enters a partner's formulary.
Recurring follow-up
Scheduled follow-ups and repeat labs for ongoing programs.
How the service line runs through the TelePartners Studio model
Patient Acquisition
Content and Meta ads for longevity programs, reviewed carefully because most products are not FDA-approved for the marketed indication.
Landing Page
A program landing page with claims limited to what counsel has approved.
Intake & Checkout
Intake collects health history and routes patients to baseline labs, such as IGF-1 and a hormone panel.
Provider Video Visit
A licensed clinician reviews history and labs in a video visit.
Prescription When Appropriate
The clinician decides independently whether a protocol is appropriate, choosing only from substances cleared for the partner's formulary.
Pharmacy Fulfillment
Compounded products ship from a state-licensed 503A or 503B pharmacy in line with current FDA guidance.
Follow-up labs, such as IGF-1 for secretagogue therapy, run on a recurring cadence through the lab integration layer.
The components behind this service line
Medications and labs below are illustrative, drawn from the TelePartners Studio Service Line Reference Guide. Each partner's independent medical director finalizes the formulary, lab panels, and visit protocols.
Protocol classes
Compounded growth-hormone-releasing peptides (sermorelin, CJC-1295, ipamorelin), NAD+, and tesamorelin, the one FDA-approved product in this class, for a narrow indication.
Baseline & follow-up labs
IGF-1, comprehensive metabolic panel and CBC, a full hormone panel, fasting glucose/HbA1c, and hs-CRP depending on the program.
Formulary review
Each peptide's FDA, DEA, and state-board status confirmed by counsel before it is added.
Compounding pharmacy
Fulfillment only through state-licensed 503A/503B pharmacies.
Insulin-sensitivity monitoring
Glucose monitoring, since growth-hormone pathway agents can affect insulin sensitivity.
Quarterly re-checks
Formularies re-checked quarterly as FDA bulk-substance lists change.
What to plan for before this service line goes live
FDA bulk-substance lists
BPC-157 and a growing list of other peptides are on FDA's Category 2 bulk-substance exclusion list and generally may not be legally compounded or dispensed.
Per-substance counsel review
Counsel should confirm current FDA, DEA, and state-board status for each peptide before it goes into any partner's formulary.
Quarterly re-checks
FDA bulk-substance lists change, so formularies should be re-checked at least quarterly.
Marketing claims
Most products are not FDA-approved for the marketed indication. Content, ads, and landing pages should avoid unsupported benefit claims and be reviewed for FTC/FDA compliance.
Corporate practice of medicine
Partners should operate through a compliant physician-owned professional entity or MSO structure, with TelePartners Studio's technology and marketing role kept separate from clinical decision-making.
Final state-specific requirements, formularies, protocols, and coverage should be reviewed by the appropriate medical and legal professionals before launch. TelePartners Studio provides technology, marketing, and operational support. It does not practice medicine or provide legal advice, and every prescribing decision is made independently by the treating licensed clinician.
Launch a premium category with compliance built in from day one
Related service lines: Women's Health / OB-GYN & Men's Health·Weight Loss & Cardiometabolic Health·Diagnostics & Lab Work Integration
Ready to launch this telehealth service line?
Talk with TelePartners Studio about building and launching a longevity and peptide therapy service line in your target market.
Book a Discovery Call